Skip to content
Washington University School of Medicine in St. Louis

Hospital Medicine Virtual Journal Club

Menu
  • About
  • Archives
  • FAQs
  • How to Access Full-text Articles
  • How to Use
  • Privacy Policy and Terms of Use

Category: bmj open

Has the introduction of direct oral anticoagulants (DOACs) in England increased emergency admissions for bleeding conditions? A longitudinal ecological study.

bmj open • June 1, 2020

Can Waterlow score predict 30-day mortality and length of stay in acutely admitted medical patients (aged ≥65 years)? Evidence from a single centre prospective cohort study.

bmj open • November 16, 2019

Factors associated with non-beneficial treatments in end of life hospital admissions: a multicentre retrospective cohort study in Australia.

bmj open • November 7, 2019

Comparing the predictive ability of a commercial artificial intelligence early warning system with physician judgement for clinical deterioration in hospitalised general internal medicine patients: a prospective observational study.

bmj open • October 12, 2019

Risk scores identifying elderly inpatients at risk of 30-day unplanned readmission and accident and emergency department visit: a systematic review.

bmj open • August 1, 2019

Is high-sensitivity troponin, alone or in combination with copeptin, sensitive enough for ruling out NSTEMI in very early presenters at admission? A post hoc analysis performed in emergency departments.

bmj open • June 19, 2019

Unintended discontinuation of medication following hospitalisation: a retrospective cohort study.

bmj open • June 7, 2019

Factors associated with peripheral intravenous cannulation first-time insertion success in the emergency department. A multicentre prospective cohort analysis of patient, clinician and product characteristics.

bmj open • April 5, 2019

Morphine in acute coronary syndrome: systematic review and meta-analysis.

bmj open • March 18, 2019

Chest pain in general practice: a systematic review of prediction rules.

bmj open • March 2, 2019

Follow Us!

Follow Us on FacebookFollow Us on TwitterFollow Us on Instagram

Journal Club via Email

The HMVJC Minute Podcast

Subscribe Now!
  • AnchorAnchor
  • Apple PodcastsApple Podcasts
  • BreakerBreaker
  • Google PodcastsGoogle Podcasts
  • iHeartRadioiHeartRadio
  • PocketCastsPocketCasts
  • PodbayPodbay
  • Radio PublicRadio Public
  • SpotifySpotify
  • TikTokTikTok
  • YouTubeYouTube

Recent Comments

  • Anonymous on Things We Do for No Reason™: Obtaining Urine Testing in Older Adults With Delirium Without Signs or Symptoms of Urinary Tract Infection
  • agario unblocked on Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
  • Ronald M. Chavin on What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak
  • An Examination of Ivermectin and Other Promising Medications in the Prevention and Treatment of COVID | Compounding Corner Pharmacy, Inc. on Montelukast in Hospitalized Patients Diagnosed with COVID-19
  • Nathan Martin on Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial

The HMVJC COVID Reading List

  • Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
  • Efficacy and Safety of Intensified Versus Standard Prophylactic Anticoagulation Therapy in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
  • Elevated D-dimer and Adverse In-hospital Outcomes in COVID-19 Patients and Synergism with Hyperglycemia
  • Occurrence and outcomes of possible superadded infections in older adults with COVID-19-cohort study
  • Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: A randomized clinical trial
  • Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
  • Re-examining the widespread policy of stopping SGLT2 inhibitors during acute illness: A perspective based on the updated evidence
  • Tocilizumab Versus Baricitinib in Patients Hospitalized With COVID-19 Pneumonia and Hypoxemia: A Multicenter Retrospective Cohort Study
  • Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized with COVID-19: A Blinded Randomized Placebo-Controlled Trial
  • Ivermectin for preventing and treating COVID-19

Links

  • WU School of Medicine
  • Dept. of Medicine
  • Division of Hospital Medicine
  • Becker Medical Library
  • Society of Hospital Medicine
  • Today's Hospitalist

Editor: Robert J. Mahoney, M.D., CCS-P, SFHM

Powered by
PubMed

©2022 Washington University in St. Louis